Last reviewed · How we verify
Quetiapine Fumarate Tablets 25 mg — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Quetiapine Fumarate Tablets 25 mg (Quetiapine Fumarate Tablets 25 mg) — IPCA Laboratories Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Quetiapine Fumarate Tablets 25 mg TARGET | Quetiapine Fumarate Tablets 25 mg | IPCA Laboratories Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Quetiapine Fumarate Tablets 25 mg CI watch — RSS
- Quetiapine Fumarate Tablets 25 mg CI watch — Atom
- Quetiapine Fumarate Tablets 25 mg CI watch — JSON
- Quetiapine Fumarate Tablets 25 mg alone — RSS
Cite this brief
Drug Landscape (2026). Quetiapine Fumarate Tablets 25 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/quetiapine-fumarate-tablets-25-mg. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab